Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts

American Journal of Physiology - Cell Physiology

Volumn 280, Issue 1 49-1, 2001, Pages

  Siwik, Deborah A ^a   Pagano, Patrick J ^b   Colucci, Wilson S ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Glucose 6 phosphate dehydrogenase; H2O2; In vitro; Reactive oxygen species; Superoxide; Superoxide dismutase

Indexed keywords

CATALASE; COLLAGEN; DIETHYLDITHIOCARBAMIC ACID; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MATRIX METALLOPROTEINASE; PRASTERONE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; FIBROBLAST; HEART MUSCLE; HEART VENTRICLE REMODELING; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT;

ANIMALIA;

EID: 0034995893     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.2001.280.1.c53     Document Type: Article

References (41)

1. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: A key role for reactive oxygen species in ischemic brain injury
2. 2 exposure
3. Fibroblast selection in scleroderma. An alternative model of fibrosis
4. Hormonal regulation of cardiac fibroblast function
5. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts
6. Collagen expression in mechanically stimulated cardiac fibroblasts
7. Stretch-induced programmed myocyte cell death
8. Regulation of collagen degradation in the rat myocardium after infarction
9. Myocardial matrix metalloproteinase activity and abundance with congestive heart failure
10. Role of oxidative stress in transition of hypertrophy to heart failure
11. Localization of types I, III and IV collagen mRNAs in rat heart cells by in situ hybridization
12. Collagen chain mRNAs in isolated heart cells from young and adult rats
13. Differential effects of transforming growth factor-β1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors
14. Effects of endothelins on collagen turnover in cardiac fibroblasts
15. Endothelial cell induced modulation of cardiac fibroblast collagen metabolism
16. The inactivation of copper-zinc superoxide dismutase by diethyldithiocarbamate
17. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats
18. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium
19. The effects of ultraviolet A and reactive oxygen species on the mRNA expression of 72-kDa type IV collagenase and its tissue inhibitor in cultured human dermal fibroblasts
20. Dynamic state of collagen: Pathways of collagen degradation in vivo and their possible role in regulation of collagen mass
21. Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure: A potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure
22. Activation of matrix metalloproteinases in the failing human heart: Breaking the tie that binds
23. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-α and angiotensin II
24. Targeted disruption of the housekeeping gene encoding glucose-6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress
25. Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: Pathogenetic implications
26. Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery
27. Controlling myocardial matrix remodeling: Implications for heart failure
28. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice
29. Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression
30. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro
31. Matrix metalloproteinase inhibition during the development of congestive heart failure: Effects on left ventricular dimensions and function
32. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: Relation to ventricular and myocyte function
33. Hypertrophic stimuli induce transforming growth factor-β1 expression in rat ventricular myocytes
34. Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes
35. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy
36. Importance of glucose-6-phosphate dehydrogenase activity in cell death
37. Importance of glucose-6-phosphate dehydrogenase activity for cell growth
38. Reduction-oxidation (redox) state regulation of extracellular matrix metalloproteinases and tissue inhibitors in cardiac normal and transformed fibroblast cells
39. Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart-derived fibroblast and endomyocardial endothelial cells
40. Differential regulation of extracellular matrix metalloproteinase and tissue inhibitor by heparin and cholesterol in fibroblast cells
41. Myocardial matrix metalloproteinase(s): Localization and activation